Increased arterial stiffness in children and adolescents with type 1 diabetes: No association between arterial stiffness and serum levels of adiponectin

Pediatric Diabetes

Volumn 11, Issue 1, 2010, Pages 38-46

  Galler, Angela ^a,b   Heitmann, Amadea ^c   Siekmeyer, Werner ^a   Gelbrich, Götz ^d   Kapellen, Thomas ^a   Kratzsch, Jürgen ^d   Kiess, Wieland ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Park Hospital Leipzig   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adiponectin; Arterial stiffness; Type 1 diabetes

Indexed keywords

ADIPONECTIN; CHOLESTEROL; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADOLESCENT; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NORMAL VALUE; PARAMETER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADOLESCENT; ARTERIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; SEX FACTORS;

EID: 77954431744     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2009.00525.x     Document Type: Article

References (44)

1. Laing SP, Swerdlow AJ, Slater SD. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999, 16:466-471.
2. Laing SP, Swerdlow AJ, Slater SD. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003, 46:760-765.
3. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006, 49:298-305.
4. Soedamah-Muthu SS, Chaturvedi N, Toeller M. EURODIAB Prospective Complications Study Group: Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 2004, 27:530-537.
5. Krantz JS, Mack WJ, Hodis HN, Liu C-R, Liu C-H, Kaufman FR. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 2004, 145:452-457.
6. Järvisalo MJ, Putto-Laurila A, Jarrti L. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 2002, 51:493-498.
7. Järvisalo MJ, Raitakari M, Toikka JO. Endothelial dysfunction and increased intima media thickness in children with type 1 diabetes. Circulation 2004, 109:1750-1755.
8. Gamble G, Zorn J, Sanders G, Mac Mahon S, Sharpe N. Estimation of arterial stiffness, arterial compliance, and distensibility from M-mode ultrasound measurements of the common carotid artery. Stroke 1994, 25:11-16.
9. Giannattasio C, Failla M, Piperno A. Early impairment of large artery structure and function in type I diabetes mellitus. Diabetologia 1999, 42:987-994.
10. Giannattasio C, Failla M, Grappiolo A, Gamba PL, Paleari F, Mancia G. Progression of large artery structural and functional alterations in type I diabetes. Diabetologia 2001, 44:203-208.
11. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 2003, 348:2294-2300. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
12. Snell-Bergeon JK, Hokanson JE, Jensen L. Progression of coronary artery calcification in type 1 diabetes. Diabetes Care 2003, 26:2923-2928.
13. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996, 271:10697-10703.
14. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003, 26:2442-2450.
15. Kumada M, Kihara S, Sumitsuji S. Association of hypoadiponectemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85-89.
16. Fasshauer M, Paschke R, Stumvoll M. Adiponectin, obesity and cardiovascular disease. Biochimie 2004, 86:779-784.
17. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerosis disease. Clin Chim Acta 2004, 344:1-12.
18. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005, 19:525-546.
19. Higashiura K, Ura N, Ohata J. Correlations of adiponectin levels with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol 2004, 61:753-759.
20. Ouchi N, Kihara S, Arita Y. Novel modulator for endothelial adhesion molecules: adipocyte-deived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
21. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
22. Arita Y, Kihara S, Ouchi N. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common. Circulation 2002, 105:2893-2898.
23. Kubota N, Terauchi Y, Yamauchi T. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002, 277:25863-25866.
24. Frystyk J, Tarnow L, Krarup Hansen T, Parving HH, Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005, 48:1911-1918.
25. Hadjadj S, Aubert R, Fumeron F. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia 2005, 48:1088-1092. SURGENE Study Group; DESIR Study Group
26. Costacou T, Zgibor JC, Evans RW. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2005, 48:41-48.
27. Kromeyer-Hauschild K, Wabitsch M, Geller F. Perzentile für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001, 149:807-818.
28. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Hirai T. Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res 1987, 21:678-687.
29. Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T, Kiess W. Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study. Eur J Endocrinol 2007, 157:481-489.
30. Rydén Ahlgren A, Länne T, Wollmer P, Sonesson B, Hansen F, Sundkvist G. Increased arterial stiffness in women, but not in men, with IDDM. Diabetologia 1995, 38:1082-1089.
31. Ahlgren AR, Sundkvist G, Wollmer P, Sonesson B, Länne T. Increased aortic stiffness in women with type 1 diabetes mellitus is associated with diabetes duration and autonomic nerve function. Diabet Med 1999, 16:291-297.
32. Ahlgren AR, Astrand H, Sundkvist G, Länne T. Increased aortic stiffness is persistent in type 1 diabetic women: a follow-up study. Diabetologia 2005, 48:780-783.
33. Larsen JR, Brekke M, Bergengen L. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia 2005, 48:776-779.
34. Dahl-Jørgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia 2005, 48:1445-1453.
35. Wadwa RP. Cardiovascular disease risk in youth with diabetes mellitus. Rev Endocr Metab Disord 2006, 7:197-204.
36. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006, 55:113-118.
37. Schwab KO, Doerfer J, Krebs A. Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia. Eur J Pediatr 2007, 166:541-548.
38. Mahmud A, Feely J. Adiponectin and arterial stiffness. Am J Hypertens 2005, 18:1543-1548.
39. Araki T, Emoto M, Yokoyama H. The association of plasma adiponectin level with carotid arterial stiffness. Metabolism 2006, 55:587-592.
40. Tsioufis C, Dimitriadis K, Selima M. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J 2007, 28:1162-1169.
41. Störk S, Bots ML, Angerer P. Low levels of adiponectin predict worsening of arterial morphology and function. Atherosclerosis 2007, 194:147-153.
42. Plant S, Shand B, Elder P, Scott R. Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins. Diab Vasc Dis Res 2008, 5:102-108.
43. Dullaart RP, de Vries R, van Tol A, Sluiter WJ. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. Eur J Endocrinol 2007, 156:387-394.
44. McNulty M, Mahmud A, Feely J. Advanced glycation end-products and arterial stiffness in hypertension. Am J Hypertens 2007, 20:242-247.